Impact of Health Workers' Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey.

Meryem Merve OrenSevgi CanbazSevim MeşeAli AğaçfidanÖmer Serdil DemirEsra KaracaAyşe Rumeysa DoğruyolGökçe Hazar OtçuTufan TükekNuray Özgülnar

Published in: Vaccines (2023)

Our results suggest that even a single booster dose of BNT162b2 after initial vaccination with CoronaVac provides a protective advantage against COVID-19, especially for risk groups such as health workers and those with chronic diseases.

Keyphrases

coronavirus disease
sars cov
public health
healthcare
mental health
health information
health promotion
risk assessment
human health